ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,316, issued on July 8, was assigned to NantBio Inc. (Culver City, Calif.).
"IL7-IL 15 TxM compositions and methods" was invented by Patrick Soon-Shiong (Culver City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Contemplated compositions and methods are directed to in vivo stimulation of TN cells to differentiate to TSCM cells in the presence of tumor cells expressing tumor associated antigens or tumor and patient specific neoepitopes using a pharmaceutical composition that includes an IL-15 portion and an IL-7 portion. The TSCM cells are then isolated and expanded in vitro, preferably using a pharmaceutical composition that includes an IL-15...